EMA supporting small and medium-sized enterprises (SMEs)

On 28 January 2020 EMA updated supporting SMEs.

EMA invites SMEs and interested stakeholder organisations to complete a short survey by 10 March 2020 to help EMA understand their current challenges and tailor its future activities to their needs.

The EMA addresses the unique needs of micro, SMEs through the SME office. This dedicated interface has the sole remit of providing regulatory, financial and administrative assistance to small pharmaceutical companies.

It was set up by Commission Regulation (EC) No 2049/2005 and promotes innovation and the development of new medicines for human and veterinary use by SMEs.

Read more online
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /